United Kingdom· GB-APID-507011000001103

Bromocriptine 2.5mg tablets

A bromocriptine product containing bromocriptine, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 8 of our 19 countries.

ATC N04BC01

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about bromocriptineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Bromocriptine is registered in 8 of 19 countries.

Countries holding a registration under ATC N04BC01 (bromocriptine), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
4 of them publish a price we can compare per daily dose

Search bromocriptine products by name

Bromocriptine · ATC N04BC01

8 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Germany
Norwayprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bromocriptine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Bromocriptine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

US United States$32.93 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Bromocriptine
Manufacturer: A A H Pharmaceuticals Ltd
Country: United Kingdom (GB)
ATC code: N04BC01
ATC class: Bromocriptine
Defined daily dose: 40 mg, O
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 1

gtin
5025903001065

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

92 interactions on record for bromocriptine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check bromocriptine against other medicines How interaction checks work

Bromocriptine · interactions on record

92 records

3 severe
87 moderate
2 minor

Most severe, free to view

IsomethepteneA03AX10severe
LorcaserinA08AA11severe
PhenylpropanolaminA08AA13severe
LansoprazoleA02BC03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromocriptine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromocriptine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Belgium · Parlodel
Bulgaria · Бромокриптин Медокеми
Cyprus · Medocriptine, Pirodal
Czechia · Medocriptine
Germany · Pravidel
Estonia · Bromocriptin Richter
Spain · Parlodel
France · Parlodel
Hungary · Bromocriptin Richter
Italy · Parlodel
Lithuania · Bromocriptin Richter
Luxembourg · Pravidel
Latvia · Bromocriptin Richter
Malta · Medocriptine
Netherlands · Parlodel
Norway · Parlodel
Poland · Bromocorn
Portugal · Bromocriptina Generis, Parlodel
Romania · Brocriptin
Sweden · Pravidel
Slovakia · Medocriptine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bd447713-ef5d-4566-b80b-2e144bafc900
GET /v1/drugs/bd447713-ef5d-4566-b80b-2e144bafc900?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "507011000001103",
  "desc": "Bromocriptine 2.5mg tablets (A A H Pharmaceuticals Ltd)",
  "form": "Oral tablet",
  "vpid": "42033611000001105",
  "source": "dmd",
  "vtm_id": "774919002",
  "strength": "2.5 mg",
  "substance": "Bromocriptine",
  "ingredient": "Bromocriptine mesilate",
  "supplier_code": "3144701000001104"
}

API reference MCP server Plans

See everything about bromocriptine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console